Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma
Clinical trial NCT01545427 · TERMINATED
Trial details
- NCT number
- NCT01545427
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2008-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.